CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-26 | CLARKE JOHN K Director | Option exercise | +6,000 | 19,797 | ||
| 2023-04-26 | CLARKE JOHN K Director | Option exercise · Restricted Stock Unit | −6,000 | 0 | ||
| 2023-04-26 | SCHIMMEL PAUL Director | Option exercise | +6,000 | 8,890 | ||
| 2023-04-26 | SCHIMMEL PAUL Director | Option exercise · Restricted Stock Unit | −6,000 | 0 | ||
| 2023-04-26 | Lucas Svetlana Director | Option exercise | +6,000 | 6,000 | ||
| 2023-04-26 | Lucas Svetlana Director | Option exercise · Restricted Stock Unit | −6,000 | 0 | ||
| 2023-04-26 | Gross Jane A Director | Option exercise | +6,000 | 6,000 | ||
| 2023-04-26 | Gross Jane A Director | Option exercise · Restricted Stock Unit | −6,000 | 0 | ||
| 2023-04-26 | COUGHLIN TIMOTHY Director | Option exercise | +6,000 | 6,000 | ||
| 2023-04-26 | COUGHLIN TIMOTHY Director | Option exercise · Restricted Stock Unit | −6,000 | 0 | ||
| 2023-02-16 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (right to buy) | +336,096 | 336,096 | ||
| 2023-02-16 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +84,023 | 84,023 | ||
| 2023-02-16 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (right to buy) | +84,023 | 84,023 | ||
| 2023-02-06 | Broadfoot Jill Marie Chief Financial Officer | Sale | −1,566 | $2.36 | $4K | 15,460 |
| 2023-02-03 | DENYES NANCY General Counsel | Option exercise | +2,688 | 7,079 | ||
| 2023-02-03 | DENYES NANCY General Counsel | Option exercise · Restricted Stock Unit | −2,688 | 8,062 | ||
| 2023-02-03 | Broadfoot Jill Marie Chief Financial Officer | Option exercise | +3,750 | 17,026 | ||
| 2023-02-03 | Broadfoot Jill Marie Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,750 | 11,250 | ||
| 2023-02-03 | Shukla Sanjay President and CEO | Option exercise | +10,375 | 61,173 | ||
| 2023-02-03 | Shukla Sanjay President and CEO | Option exercise · Restricted Stock Unit | −10,375 | 31,125 |
Page 5 of 15 · 284 trades